Cargando…
Can early measles vaccination control both measles and respiratory syncytial virus infections?
Measles virus and respiratory syncytial virus (RSV) are two important global health pathogens causing substantial morbidity and mortality worldwide. The current measles vaccination schedule has the first dose given at 9–12 months of age and the second dose given at 15–18 months of age. Measles outbr...
Autores principales: | Do, Lien Anh Ha, Toh, Zheng Quan, Licciardi, Paul Vincent, Mulholland, Edward Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694706/ https://www.ncbi.nlm.nih.gov/pubmed/34953518 http://dx.doi.org/10.1016/S2214-109X(21)00464-2 |
Ejemplares similares
-
Can data from paediatric cohorts solve the COVID-19 puzzle?
por: Do, Lien Anh Ha, et al.
Publicado: (2020) -
Brief communication: immunogenicity of measles vaccine when co-administered with 10-valent pneumococcal conjugate vaccine
por: Toh, Zheng Quan, et al.
Publicado: (2020) -
Measles–mumps–rubella vaccination and respiratory syncytial virus-associated hospital contact
por: Sørup, Signe, et al.
Publicado: (2015) -
The measles emergency is over, but the crisis continues – a call to action for the Pacific Islands
por: Kaspar, Annette, et al.
Publicado: (2020) -
Control of the COVID-19 pandemic is derailing the fight against typhoid, dengue, and measles in Pakistan
por: Rana, Muhammad S, et al.
Publicado: (2022)